Atrovent
Product Images NDC 50090-0961

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Atrovent (NDC 50090-0961). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atrovent Figure 1 (Atroventhfa Fig1)

Two line graphs labeled Day 1 and Day 85 comparing FEV1 (liters) over 8 hours after drug administration for placebo and three dosages of ipratropium bromide HFA and CFC (42 mcg, 84 mcg) in Atrovent HFA clinical data.*

FDA Label Image

Atrovent Diag. 1 (Atroventhfa Pic1)

An instructional diagram showing the parts of an Atrovent HFA inhaler, including the canister, mouthpiece, dose indicator, and dustcap. The image visually labels each component of the inhaler device.*

FDA Label Image

Atrovent Diag. 2 (Atroventhfa Pic2)

A horizontal bar chart displaying numeric values descending from 200 down to 0 in intervals of 20. The values are arranged in a gradient bar with darker shading from the lower numbers to lighter shading toward higher numbers, highlighting the region around 40.*

FDA Label Image

Atrovent Diag. 3 (Atroventhfa Pic3)

An instructional illustration showing a person using an inhaler by placing it in their mouth and pressing down on the canister to release the medication. The image visually demonstrates proper inhaler usage technique.*

FDA Label Image

Atrovent Diag. 4 (Atroventhfa Pic4)

An instructional diagram showing a person using the Atrovent HFA inhaler, demonstrating how to position the device near the mouth and inhale the medication.*

FDA Label Image

Atrovent Diag. 5 (Atroventhfa Pic5)

An illustration showing a person using an inhaler device, holding it near their mouth and preparing to inhale the medication.*

FDA Label Image

Atrovent Diag. 6 (Atroventhfa Pic6)

An illustration showing a person holding and removing the cap from an Atrovent HFA inhaler. The drawing highlights the proper handling of the inhaler device, likely as part of usage instructions.*

FDA Label Image

Atrovent Diag. 7a (Atroventhfa Pic7a)

An illustration showing a close-up of a dose counter window on an Atrovent HFA inhaler. The counter displays numeric increments (60, 40, 20) to indicate remaining doses, with an arrow pointing below the number 40.*

FDA Label Image

Atrovent Diag. 7b (Atroventhfa Pic7b)

Atrovent HFA inhaler dose counter display showing a remaining dose count near 20. The image focuses on the digital dose counter window of the Atrovent HFA inhaler, a product by A-S Medication Solutions.*

FDA Label Image

Atroventhfa-structure (Atroventhfa Structure)

Chemical structure diagram of the active ingredient in Atrovent HFA, showing its molecular arrangement including a quaternary ammonium group, a benzene ring, and associated ions bromide and water of hydration.*

FDA Label Image

Label Image (Lbl500900961)

Atrovent HFA inhalation aerosol, 17 mcg per actuation, labeled as containing 200 metered actuations. The product is from A-S Medication Solutions LLC. The label indicates each actuation delivers 17 micrograms and specifies storage instructions at 77 degrees Fahrenheit, with total weight approximately 12.9 grams. The label includes a QR code and barcode with dosage packaging information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.